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Abstract
Connexin 43 (Cx43), the gap junction protein involved in cell-to-cell coupling in the heart, is also present in the subsarcolemmal fraction of car-
diomyocyte mitochondria. It has been described to regulate mitochondrial potassium influx and respiration and to be important for ischaemic
preconditioning protection, although the molecular effectors involved are not fully characterized. In this study, we looked for potential partners
of mitochondrial Cx43 in an attempt to identify new molecular pathways for cardioprotection. Mass spectrometry analysis of native immunopre-
cipitated mitochondrial extracts showed that Cx43 interacts with several proteins related with mitochondrial function and metabolism. Among
them, we selected for further analysis only those present in the subsarcolemmal mitochondrial fraction and known to be related with the respi-
ratory chain. Apoptosis-inducing factor (AIF) and the beta-subunit of the electron-transfer protein (ETFB), two proteins unrelated to date with
Cx43, fulfilled these conditions, and their interaction with Cx43 was proven by direct and reverse co-immunoprecipitation. Furthermore, a previ-
ously unknown molecular interaction between AIF and ETFB was established, and protein content and sub-cellular localization appeared to be
independent from the presence of Cx43. Our results identify new protein–protein interactions between AIF-Cx43, ETFB-Cx43 and AIF-ETFB as
possible players in the regulation of the mitochondrial redox state.
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Introduction
Connexin 43 (Cx43) is the predominant connexin isoform in ventricu-
lar myocardium. It is widely known to participate in cell-to-cell propa-
gation of the electrical impulse as well as in chemical communication
between adjacent cells. As a pore-forming molecule, it is composed
of four transmembrane domains as well as intracellular amino- and
carboxyterminal domains [1]. Connexins are assembled in groups of
six units to form hemichannels, or connexons, that may come into
contact with a hemichannel from a neighbouring cell to form a gap
junction (GJ) channel. These intercellular channels conform a special-
ized membrane area of chemical communication that usually inte-
grates other adhesion structures, such as desmosomes or adherens
junctions [2]. Importantly, channel activity is determined by the con-
duction properties of the connexin involved. Thus, Cx43 connexons
have a minimal diameter pore of 15 A, with a relative anion-to-cation
selectivity ratio of 1.17, and an intermediate unitary conductance of
100 pS [3–5].
Besides their role in the formation of permeable transmembrane
channels ensuring electrical and metabolic coupling between cells,
Cx43 has been shown to participate in several signalling pathways [6,
7]. Normal sodium and potassium currents appear to be dependent
on Cx43 expression [8, 9], and therefore, any alteration of this protein
can modify the action potential of cardiomyocytes with arrhythmo-
genic consequences. Connexins may also control cell growth and
inhibit tumorigenicity in different cell types; it has been proved that
overexpression of Cx43 in neonatal rat cardiomyocytes decreases
DNA synthesis [10]. In Cx43-deficient mice, embryonic development
is compromised and animals die at birth due to swelling and blockage
of the right ventricular outflow tract from the heart [11]. At the con-
nexon level, several mechanisms nonrelated to GJ communication
have been proposed to modulate cell death and survival, paracrine
factors release, volume regulation or activation of signal transduction
pathways [12]. Although the end effectors of these mechanisms
remain poorly established, a complete understanding of connexin
function has been achieved when defining its molecular interactors,
like kinases, phosphatases or other molecules regulated by receptor
stimulation or subcellular localization [13].
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Furthermore, Cx43 is involved in myocardial energy metabolism,
tolerance to ischaemia and preconditioning protection—i.e. protec-
tion against cell death obtained by brief non-lethal episodes of
ischaemia preceding prolonged severe ischaemia [14, 15]. Most of
the signalling pathways of ischaemic preconditioning converge on
mitochondria, and recent reports have shown that in cardiomyocytes
Cx43 is also located at the inner membrane of subsarcolemmal
mitochondria (SSM), whereas it is nearly absent at interfibrillar mito-
chondria (IFM) [16, 17]. In vitro cross-linking studies show mito-
chondrial complexes with a molecular weight comparable to that of
sarcolemmal Cx43 hemichannels; in addition, those complexes are
sensitive to carbenoxolone and heptanol, two hemichannel blockers
[18]. It has also been described that mitochondrial Cx43 (mtCx43)
modulates mitochondrial potassium influx and respiration [18, 19].
Moreover, in the presence of mtCx43, ischaemic preconditioning
prevents reperfusion-induced respiratory failure and oxidative dam-
age, whereas lack of mtCx43 abolishes the protective effect of pre-
conditioning on myocardial infarct size [15, 20, 21]. However, the
molecular effectors of the cardioprotective role of Cx43 still remain
elusive. Mitochondrial Cx43 could regulate mitochondrial volume
and, as a consequence, respiration and reactive oxygen species
(ROS) signalling by forming hemichannels similar to those present
at the sarcolemma. Alternatively, mtCx43 could regulate mitochon-
drial function and cardioprotection by interacting with still unknown
proteins.
The aim of this study is to find new molecular partners of
mtCx43 that could participate in putative channel-independent
actions. Proteomics analysis identifies apoptosis-inducing factor
(AIF) and the beta-subunit of the electron-transfer protein (ETFB),
two unrelated proteins involved in oxidative phosphorylation and
redox control, as molecular interactors of mtCx43. Our results also
confirm that AIF and ETFB are able to interact in a Cx43-indepen-
dent manner.
Materials and methods
Mice
Adult male and female transgenic Cx43KI32 mice (developed by [22])
aged between 16 and 20 weeks (30 g) were used in this study. In these
animals, the coding region of the Cx43 gene has been replaced by that
of Cx32 as confirmed by specific PCR analysis. All protocols were
approved by the Ethics Committee on Animal Research of the Hospital
Vall d’Hebron, Barcelona, Spain. The study conforms the European
Directive on the Welfare of Research Animals (2010/63/UE).
Mitochondrial and total heart extracts
Mice heart mitochondria were prepared by differential centrifugation
[18, 23]. Briefly, for each pull down assay, 6–8 animals from both
wild-type (Cx43 WT; Cx43 homozygous genotype) and knock-in mutant
mice (Cx43 KI Cx32; Cx32 homozygous genotype), considered two sep-
arate groups, were deeply anaesthetized by an i.p. injection of sodium
pentobarbital (150 mg/kg). Whole hearts were quickly excised, minced
and homogenized with 5–10 strokes of a teflon pistill in a glass potter
at 250 r.p.m. in ice-cold isolation buffer A [in mmol/L: 290 sucrose, 5
3-(N-Morpholino)-propanesulfonic acid (MOPS), 2 ethylene glycol-bis(2-
aminoethylether)-N,N,N 0,N 0-tetraacetic acid (EGTA), 10 NaF, 2 Na3VO4
and protease inhibitors cocktail (P8340; Sigma-Aldrich, Saint Louis,
MO, USA), pH 7.4]. Samples were centrifuged at 750 g and super-
natant obtained handled as the subsarcolemmal mitochondrial fraction
(SSM). The sediment of this first centrifugation was further processed
with 2 mg proteinase K (P2308; Sigma-Aldrich)/g heart tissue in ice-
cold isolation buffer B [in mmol/L: 100 KCl, 50 MOPS, 2 EGTA, and
10% bovine serum albumin (BSA), pH 7.4] to obtain the interfibrillar
mitochondrial fraction (IFM). Two additional centrifugation steps are
necessary for mitochondrial purification. The first one at 5000 9 g to
obtain an enriched SSM and IFM fraction, followed by a second cen-
trifugation at 12,500 9 g in 17% percoll in isolation buffer A. Total
heart homogenates were attained by solubilization of 100–200 mg of
tissue in lysis buffer [2% n-Dodecyl b-D-maltoside (D4641; Sigma-
Aldrich), 20 mmol/L TEA pH 8, 20 mmol/L ethylenediaminetetraacetic
acid, 10 mmol/L DTT and protease inhibitors cocktail]. All samples
were kept on ice for immediate use, and protein concentration was
determined by Bradford assay.
Co-Immunoprecipitation experiments
A total of 0.8–1 mg of protein was used for each pull down reaction
with 10 lg of rabbit anti-connexin-43 antibody (C6219; Sigma-
Aldrich), mouse anti-apoptosis-inducing factor antibody (MA5-15880;
Pierce-Thermo Scientific, Rockford, IL, USA), rabbit anti-ETFB subunit
beta antibody (17925-1-AP; ProteinTech, Manchester, UK), respec-
tively, according the Pierce Crosslink Immunoprecipitation Kit manu-
facturer’s instructions (26147; Thermo Scientific, Rockford, IL, USA).
Total and mitochondrial heart extracts were treated in non-denaturing
conditions with buffers supplied, and protein-antibody-agarose beads
complexes incubated at 4°C during 16 hrs with an end-over-end mix-
ing. After washing, bound proteins were eluted (low pH) and pre-
served for posterior proteomics analysis and Western blotting.
Proteomics
Protein digestion
The resulting soluble protein extracts were run on a SDS-PAGE gel
(10% resolving gel and 4% stacking gel) at 50 V. The electrophoresis
was stopped when the front dye has barely passed into the resolving
gel, ensuring concentration of all proteins into a unique band. Staining
was performed using GelCode Blue Stain Reagent (Thermo Scientific).
Gel pieces were cut into cubes (2 mm). For the protein digestion, modi-
fied porcine trypsin (Promega, Fitchburg, WI, USA) was added at a final
ratio of 1:20 (trypsin-protein). Digestion proceeded overnight at 37°C in
100 mM ammonium bicarbonate, pH 8.8.
Identification of proteins by liquid chromatography coupled
to tandem mass spectrometry
The resulting tryptic peptide mixtures were subjected to nano-liquid
chromatography coupled to mass spectrometry (LC-MS) for protein
identification. Peptides were injected onto a C-18 reversed phase (RP)
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nano-column (75 lm I.D. and 50 cm, Acclaim PepMap100; Thermo Sci-
entific) and analysed in a continuous acetonitrile gradient consisting of
0–30% B in 240 min. and 50–90% B in 3 min. (B = 90% acetonitrile,
0.5% acetic acid). A flow rate of ca. 200 nl/min. was used to elute pep-
tides from the RP nano-column to an emitter nanospray needle for real-
time ionization and peptide fragmentation on a Orbitrap Elite mass spec-
trometer (Thermo Fisher, San Jose, CA, USA). An enhanced FT-resolu-
tion spectrum (resolution = 120,000) followed by the MS/MS spectra
from most intense fifteen parent ions was analysed along the chromato-
graphic run (272 min.). Dynamic exclusion was set at 30 sec. For pro-
tein identification, tandem mass spectra were extracted and charge
state deconvoluted by Proteome Discoverer 1.4.0.288 (Thermo Fisher
Scientific). All MS/MS samples were analysed using SEQUESTTM
(Thermo Fisher Scientific).
From an initial list of 493 identified proteins, 78 were proposed as
potential candidates according to the different proportion of peptides
detected between the SSM and IFM sample, favouring the former.
Among this list of 78, eight candidates were finally chosen according to
the following criteria (see Table S1 for full list): (i) cytoskeleton proteins
were excluded, as we were working mitochondrial specificity; (ii) pro-
teins present in the IFM sample were excluded, as Cx43 is not repre-
sented in this fraction; and finally, (iii) proteins were chosen according
to the bibliographic data available related with the functional capacity of
the organelle (UniProt Database, UniProt Consortium).
Blue-native electrophoresis and MS distribution analyses
Mitochondria-enriched samples from three different tissues (liver, heart
and brain) and from a fibroblasts cell line (fC57) were treated with 4%
digitonin to solubilize membrane proteins. Blue-native electrophoresis
(BNE) was used to separate the native complexes in a gradient gel from
4% to 13% acrylamide. Staining was performed using GelCode Blue
Stain Reagent (Thermo Scientific). Each lane was divided and excised in
26 bands covering the whole electrophoretic run. Gel pieces were then
digested with trypsin following the aforementioned protocol, and the
resulting tryptic peptide mixtures were subjected to LC-MS analysis for
identifying the proteins present on each band.
Suborganelle protein localization
To assess the mitochondrial localization of the different proteins of inter-
est, 100–300 lg of SSM protein, either from wild-type or knock-in mutant
mice, was incubated for 10 min. on ice with different proteinase K con-
centrations (0.1–0.5 lg/ml; Sigma-Aldrich), in order to partially digest the
outer membrane. Samples were further analysed by Western blotting.
Western blot
Protein samples (25–30 lg of total protein/lane) were mixed 1:1 with
29 protein loading buffer (60 mmol/L Tris-HCl pH 6.8, 10% glycerol,
2% SDS, 1% bromophenol blue, 10% beta-mercaptoethanol), boiled
5 min. at 98°C and loaded onto 12% SDS-PAGE gels. Proteins were
detected by Western blotting using: rabbit anti-Cx43 antibody (C6219;
Sigma-Aldrich), mouse anti-AIF antibody (MA5-15880; Pierce-Thermo
Scientific), rabbit anti-ETFB antibody (17925-1-AP; ProteinTech), mouse
anti-Na+/K+ ATPase alpha-1 antibody (05-369; Millipore, Billerica, MA,
USA), mouse anti-SDHA (MS204; MitoSciences, Eugene, OR, USA),
mouse anti-Pan Cadherin (C1821; Sigma-Aldrich) and rabbit anti-
TOMM20 antibody (HPA011562; Sigma-Aldrich).
Immunofluorescent assays
Isolation of adult cardiac myocytes
Adult cardiac cells from either wild-type or knock-in Cx43 mice were
obtained by retrograde collagenase perfusion [15]. Briefly, adult mice
were deeply anaesthetized by an i.p. injection of sodium pentobarbital
(150 mg/kg), and the heart was perfused in a Langendorff system
for 15 min. with a modified Krebs buffer with 0.03% type II collage-
nase (17456; Serva Electrophoresis, Heidelberg, Germany). Calcium-
tolerant rod-shaped cardiomyocytes were selected by gravity sedimen-
tation in 4% BSA gradient and plated on laminin-coated cover slips.
Subcellular localization assays
Isolated cardiomyocytes were fixed and permeabilized with ice-cold ace-
tone during 8 min. at RT. After washing with PBS + 0.025% Triton X-
100, samples were blocked with 1% BSA in PBS for 45 min. at RT and
immunodetected using rabbit anti-Cx43 antibody (C6219; Sigma-
Aldrich), mouse anti-AIF antibody (MA5-15880; Pierce-Thermo Scien-
tific), rabbit anti-ETFB antibody (17925-1-AP; ProteinTech), mouse anti-
SDHA (MS204; MitoSciences) and rabbit anti-VDAC antibody (ab15895;
AbCam, Cambridge, UK) as primary antibodies and AlexaFluor 488-con-
jugated antimouse (A-11001; Molecular Probes, Thermo Scientific,
Rockford, IL, USA) and AlexaFluor 594-conjugated anti-rabbit (A-11012;
Molecular Probes) as secondary antibodies. Finally, cardiomyocytes
were washed twice with PBS and nuclei were stained with Hoeschst
33342 (10 lg/ml). Confocal fluorescent images were captured with a
spectral microscope (Olympus Spectral Confocal Microscopy FV1000,
Olympus, Center Valley, PA, USA). Images were captured taken into
account that the pixel size was set to 1/2 of the optical resolution, and
quantitative data were obtained with ImageJ software analysis (JACoP
plug-in) [24].
Proximity ligation assay
Cardiomyocytes from either wild-type or knock-in Cx43 mice were iso-
lated, plated in cover slips and incubated with the corresponding primary
antibodies as previously described. Preparations were then tested using
the DuoLink kit secondary antibodies conjugated with the corresponding
proximity ligation assay (PLA) probes (DUO92101; Sigma-Aldrich) for
1 hr 37°C. For ligation and amplification reactions, DuoLink in situ detec-
tion kit recommendations were followed. Cell images were obtained with
spectral microscope (Olympus Spectral Confocal Microscopy FV1000) as
stated above. Positive cross-reactivity was quantified in background-sub-
tracted images using BlobFinder software (developed by: Carolina
W€ahlby and Amin Allalou at CBA, Uppsala University) [25].
Statistics
Data are expressed as mean  S.E.M. Student’s t-test was used to
compare Manders’ coefficients and PLA quantification values between
Cx43 WT and Cx43 KI Cx32 transgenic animals. Differences were
considered significant when P < 0.05.
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Results
Mitochondrial Cx43 interacts with proteins
related with the respiratory electron chain
To examine new molecular partners of Cx43, a first set of
immunoprecipitation experiments was done in non-denaturing
conditions to preserve and analyse potential protein–protein inter-
actions. Cardiac subsarcolemmal (SSM) and interfibrillar (IFM)
mitochondrial extracts were purified from Cx43 WT mice hearts
and 1 mg of total protein was processed with a specific anti-
Cx43 antibody. IFM elution sample obtained was used as a nega-
tive control, as Cx43 is virtually absent in this mitochondrial pop-
ulation [17]. Protein content of the eluted fractions was analysed
by mass spectrometry and final results are summarized in
Table 1.
To sum up, from an initial list of 78 protein candidates, eight
were finally chosen based on its involvement in mitochondria func-
tion. When candidates were examined focusing on its main biologi-
cal function, three of them had special interest for being
associated to mitochondrial respiration, as Cx43 is described to
have an impact on respiratory complex I activity and oxygen con-
sumption [19]. Ndufs6 is an accessory subunit of the mitochon-
drial membrane respiratory chain NADH dehydrogenase (Complex
I) that is believed not to be involved in catalysis; Etfb, in associa-
tion with Etfa, acts as an electron carrier from fatty acid beta-oxi-
dation to the electron transport chain via ETF-ubiquinone
oxidoreductase; and finally, Aifm1 is mostly known as a caspase-
independent apoptogenic molecule but, in the absence of specific
death signals, it has a NADH oxidoreductase activity (biological
process extracted from UniProt Database).
Mitochondrial Cx43 co-immunoprecipitates with
AIF and ETFB
Because no previous interaction has been described so far for these
proteins, we next proceeded to confirm the proteomics results by
Western blot analysis of the immunoprecipitated samples (Fig. 1A).
For this purpose, we used purified SSM mitochondrial extracts from
Cx43 WT mice, including the IFM fraction as a negative control. A
good recovery of endogenous Cx43 was achieved, and a faint band
was detected in the eluted samples, both for ETFB and AIF proteins
(Fig. 1A, lanes 4–6 arrows), although AIF content on SSM Cx43-
immunoprecipitated sample was barely perceptible. In addition, when
performing reverse co-immunoprecipitation to analyse the presence
of Cx43 in the anti-ETFB and anti-AIF eluted samples, Cx43 was pre-
sent in both mitochondrial extracts, most notably in the SSM fraction,
validating the proteomics results (Fig. 1A, lanes 7–12 arrows).
We were unable to prove any co-immunoprecipitation of Cx43
with NDUFS6 (data not shown), and so it was discarded from our
study.
Remarkably, the AIF-immunoprecipitated fraction showed reactiv-
ity against ETFB, pointing to a new protein interaction between these
two proteins (Fig. 1A, lane 9 asterisk).
Mitochondrial protein amount or sub-organelle
distribution of ETFB and AIF is not dependent on
the presence of Cx43
Evidence from the immunoprecipitation assay prompted us to investi-
gate if Cx43 content could either modulate protein amount or sub-
localization of ETFB and AIF in mitochondria. ETFB is supposed to
Table 1 Eluted samples from three independent Cx43 immunoprecipitation experiments were analysed and the most regular results were
selected from a total of 80 candidates. Gene, UniProt code and complete name are shown, and the biological processes known indicated
Gene Protein UniProt Protein name Biological process
Gja1 Cx43 P23242 Gap junction alpha-1 protein Cx43 - gap junction channel
Eci1 ECI1 P42125 Enoyl-CoA delta isomerase 1 Fatty acid beta-oxidation
Pfkm PFKM P47857 ATP-dependent 6-phosphofructokinase Carbohydrate degradation, glycolysis
Ndufs6 NDUS6 P52503 NADH dehydrogenase [ubiquinone]
iron-sulphur protein 6
Electron transport, respiratory chain
Echs1 ECHS1 Q8BH95 Enoyl-CoA hydratase Fatty acid beta-oxidation
Acat1 ACAT1 Q8QZT1 Acetyl-CoA acetyltransferase Ketone body metabolism
Cs CS Q9CZU6 Citrate synthase Tricarboxylic acid cycle
Etfb ETFB Q9DCW4 Electron-transfer flavoprotein subunit beta Electron transport, electron carrier
Aifm1 AIF Q9Z0X1 Apoptosis-inducing factor 1 Apoptosis, cell redox homeostasis, respiratory
chain complex I assembly
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remain in the mitochondrial matrix, and AIF displays an inner mem-
brane-anchored mature form and an intermembrane-matrix-soluble
form just after a proteolytic stimulus [26]. We first studied the total
protein amount in whole heart samples and in SSM and IFM fractions
from Cx43 WT and Cx43 KI Cx32 animals, respectively (Fig. 1B). No
significant differences in protein content were found between both
genotypes.
When exploring the mitochondrial distribution, 1–300 lg of SSM
protein extract were digested with 0.1 and 0.5 lg of proteinase K to
eliminate the outer mitochondrial membrane and expose the inter-
membrane matrix and the inner mitochondrial membrane (Fig. 1C).
AIF was sensitive to proteinase K action, and proteolysis of the
anchored mature form was detected as a double band of lower molec-
ular weight (Fig. 1C lanes 3 and 4). Overall, no statistically significant
differences in protein pattern were found related to Cx43 presence,
suggesting that sub-organelle localization of AIF or ETFB does not
depend on their interaction with Cx43.
Sub-cellular localization of Cx43, ETFB and AIF
in cardiomyocyte mitochondria
We next investigated if mitochondrial Cx43 is coincident with sub-cel-
lular localization of AIF and ETFB (Fig. 2). For this purpose, adult iso-
lated cardiomyocytes from both Cx43 WT or Cx43 KI Cx32 mice were
immunolabelled with anti-AIF, anti-ETFB or anti-Cx43. Positive label-
ling of mitochondrial proteins SDHA and VDAC were used as control
(Fig. 2A). Manders’ coefficients M1 and M2 were quantified with
Fig. 1Western Blot analysis of protein co-immunoprecipitation and mitochondrial distribution of Cx43, ETFB and AIF in WT and Cx43KICx32 mice.
(A) A total amount of 1 mg of heart mitochondrial protein extracts from WT mice was immunoprecipitated using anti-Cx43, anti-AIF and anti-ETFB
antibodies. In left panels, lanes from 1 to 3 correspond to the input sample, the initial total (T), subsarcolemmal (SSM) or interfibrillar (IFM) protein
extracts. Lanes from 4 to 12 correspond to the output sample—the immunoprecipitated fraction—analysed for the presence of each protein. A rep-
resentative IgG control of Cx43-IP protocol is shown in right panels using the total protein extract as a sample. Of note, the Cx43 antibody used
recognizes also the phosphorylated protein forms (C0 unmodified, C1 phosphorylated). Also, due to proteinase treatment to obtain the IFM fraction,
AIF is partially truncated and noted as a double lower molecular weight band. (B) Protein content of Cx43, AIF and ETFB. Anti-SDHA was used as a
mitochondrial loading control. (C) Sub-mitochondrial distribution of Cx43, AIF and ETFB proteins was examined after partial digestion of the outer
mitochondrial membrane with 0.1 and 0.5 lg of proteinase K, as indicated. Na+/K+ ATPase reactivity was assessed to rule out any potential contam-
ination from gap-junctional membranes, and SDHA and TOMM20 were used as an inner and outer mitochondrial membrane protein control, respec-
tively. A representative image of at least three independent replicates is shown.
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ImageJ software (Fig. 2B). On the whole, 51.9  3.3% of Cx43 label-
ling co-localized with ETFB, and 70.4  2.3% with AIF, results that
suggest a strongest co-localization with AIF protein in the mitochon-
dria. Manders’ coefficient between ETFB and AIF labelling was
63.9  1.6% in WT versus 65.5  1.3% in KI mice. Manders’ coeffi-
cient between AIF and ETFB labelling was 86.4  1.6% in WT versus
Fig. 2 Immunolocalization of Cx43, ETFB and AIF proteins in freshly isolated cardiomyocytes from WT and Cx43KICx32 mice. (A) Confocal micro-
scopy images showed a specific localization in cardiomyocyte membrane and mitochondria for Cx43; and presence in mitochondria for AIF and
ETFB, in agreement with bibliographic information (upper right snapshots). Co-localization (lower snapshots) of Cx43 with AIF or ETFB, and also AIF
with ETFB, is quantitatively evaluated in (B) by analysis of composed images using 8–12 z-stacks for each experimental condition, of at least three
independent cardiomyocyte isolation events for each genotype. See text for comment on Manders’ coefficients.
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75.7  3.8% in KI mice. Again, no statistically significant differences
were detected between different genotypes, suggesting a Cx43-inde-
pendent interaction.
Interaction of Cx43, ETFB and AIF in
cardiomyocyte mitochondria
To quantify the possible interaction between our proteins of interest,
we used an in situ PLA, in which a pair of labelled secondary antibod-
ies generates a fluorescent signal only if they are in close proximity
(<40 nm), either in a stable or a transient interaction, being the latter
a possible explanation for the faint levels detected with co-immuno-
precipitation assays. As shown in Figure 3, confocal images obtained
after PLA of freshly isolated adult cardiomyocytes demonstrated fluo-
rescent cross-reactivity between Cx43-AIF and Cx43-ETFB (Fig. 3A).
The number of positive fluorescent spots was 121.25  25.10 and
65.75  10.89 for Cx43-AIF and Cx43-ETFB pairs, respectively.
Apoptosis-inducing factor-ETFB protein–protein interaction was
proved to be persistent and not depending on Cx43, as quantification
of the number of fluorescent spots revealed no statistically significant
differences between genotypes: 533.5  76.82 in Cx43 WT car-
diomyocytes versus 562.5  42.66 in Cx43 KI Cx32 cardiomyocytes
(Fig. 3B).
AIF and ETFB comigrate in blue-native gels
The possible interaction between AIF and ETFB was further character-
ized by blue-native gel electrophoresis followed by mass spectrome-
try analysis of each fraction from heart, liver and brain tissues and
fC57 liver cell line. We found that AIF and ETFB had the same migra-
tion profile in the four samples analysed, suggesting the possible
interaction and formation of the same macromolecular complex of
these proteins (Fig. 4). Moreover, the molecular weight that corre-
sponds to the bands where the two proteins are identified is higher
than the molecular weight of the individual proteins. In addition, we
found that enoyl-CoA hydratase (ECHS1), a protein implicated in fatty
acid beta-oxidation, and citrate synthase (CS), implicated in tricar-
boxylic acid cycle, displayed also the same migration pattern as ETFB
and AIF in the three tissues analysed (Fig. 4). All together, these
results reinforce our data and are in agreement with previous studies
that describe the association between fatty acid oxidation enzymes
and respiratory complexes (see Discussion).
Discussion
In this study, we investigated the interaction of Cx43 with new molec-
ular partners in mitochondria from adult mouse cardiomyocytes
under non-stress conditions. By using co-immunoprecipitation
assays and second-generation proteomics, we provide evidence that
mtCx43 interacts with AIF and ETFB, two unrelated proteins to date.
This interaction was further supported by colocalization and comigra-
tion studies that also demonstrate a previously unsuspected protein–
protein interaction between AIF and ETFB. However, this same inter-
play found in mitochondria from transgenic animals lacking Cx43
suggests that these proteins may interact independently from
mtCx43, most probably within a multi-protein complex. These results
may serve as a starting point for the investigation of new aspects on
the regulation of mitochondrial function. The identification of Cx43
interactors has important practical implications as it can help to eluci-
date the molecular pathway of ischaemic preconditioning cardiopro-
tection and to propose potential pharmacological targets for the
development of new therapeutic strategies.
Apoptosis-inducing factor is an evolutionarily conserved flavopro-
tein, known as a cell death-promoting molecule after proapoptotic
signals. Nevertheless, under physiological conditions, AIF is involved
in oxidative phosphorylation and redox management [26, 27]. Data
gathered from independent studies reveal that AIF-knockout cells and
tissue-specific knockouts of the Aifm1 gene in the heart and the
skeletal muscle exhibit a reduction in respiratory complex I protein
content or/and activity [28, 29]. Most interestingly, deficient AIF mice
develop more severe heart injury when subjected to myocardial
ischaemia-reperfusion, an effect that has been related to a reduced
capacity of SSM to scavenge free radicals [30]. Importantly, these
evidences are in agreement with functional data on mitochondrial
complex I activity and ROS handling in previous studies with Cx43-
deficient mice [19, 20].
Electron-transfer flavoprotein is a mitochondrial matrix heterodi-
mer with alpha- (ETFA, 30 kD) and beta- (ETFB, 28 kD) subunits that
contains one FAD and one AMP molecule per heterodimer [31]. ETF
and ETF-ubiquinone oxidoreductase are the two enzymes required for
electron transfer from at least 11 dehydrogenases in the fatty acid
beta-oxidation cascade to the mitochondrial respiratory chain. How-
ever, very few studies have explored the role of ETF or any of its sub-
units on mitochondrial respiratory function and ROS generation. In a
recent study, Rodrigues and Gomes [32] analysed the effect of two
pathogenic point mutations in human ETFB—which are believed to
prevent its interaction with the FAD cofactor and its partner dehydro-
genases—on superoxide and hydrogen peroxide generation. Accord-
ing to their results, wild-type ETF is able to produce significant
amounts of both superoxide and hydrogen peroxide, but this reactiv-
ity is decreased when forming part of a tight protein–protein complex.
The capacity to form such protein complexes depends on ETFB sub-
unit, as disease mutants show higher production of ROS. In agree-
ment with a multi-protein scenario, other studies have shown that
fatty acid oxidation enzymes and respiratory chain complexes are
physically associated, comprising multifunctional electron-transfer
chain complexes [33].
Our data provide a new lead about the management of the redox
status in cardiomyocyte mitochondria showing that mtCx43 interacts
preferentially with AIF and also with ETF—through its beta-subunit. In
the context of available data on the roles of these proteins in the mod-
ulation of mitochondrial respiration and ROS production, these
results may indicate the participation of mtCx43, ETF and AIF in mul-
ti-protein complexes with important actions on mitochondrial physiol-
ogy. Reactive oxygen species and mitochondrial function are strongly
interconnected both in normal and dysfunctional states. The concen-
tration of these reactive species shifts the overall redox balance
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Fig. 3 In situ proximity ligation assay of Cx43, ETFB and AIF proteins in freshly isolated cardiomyocytes from WT and Cx43KICx32 mice. (A) Cells
treated with no primary antibody (negative control) or with only anti-Cx43 were used to determine the signal specificity, whereas Cx43-PanCadherin
and Cx43-SDHA pairs of proteins were used as a positive control. In the lower group of confocal images, Cx43 interacts with AIF and ETFB, as well
as AIF with ETFB in a Cx43-independent manner. (B) Assessment of the number of signals detected with composed images using 8–12 z-stacks for
each experimental condition, of at least three independent cardiomyocyte isolation events for each genotype.
ª 2016 The Authors.
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between their role as signalling molecules to their role in promoting
deleterious effects. The control of this balance may depend on various
interacting proteins working together, most probably in localized
dynamic platforms.
Further studies will be necessary to determine the composition
and functions of these putative multi-protein complexes, and in par-
ticular whether its formation may explain the important modulatory
effect of mtCx43 on mitochondrial respiration and ROS production.
Our present data indicate that mtCx43 may not be an indispensable
element in these complexes, as its absence does not appear to modify
the cellular localization of ETFB or AIF, nor the interaction between
them.
Conclusion
The present study proposes the interaction of mtCx43 with ETFB and
AIF to form multi-protein complexes with effects on mitochondrial
respiration and ROS signalling. Elucidation of the composition and
functions of such complexes could have therapeutic implications
given the important role of Cx43 on preconditioning cardioprotection.
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